Clinical Trial Update: OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing OPEN versus InTact capsule proton pump inhibitors for the treatment of marginal ulcers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Ulcer

Drugs mentioned

• InTact Capsule Proton Pump Inhibitor
• OPEN Capsule Proton Pump Inhibitor

Snippet

Sponsor: Stephen Firkins | Conditions: Marginal Ulcer | Phase 4 | Status: RECRUITING